US medical students in anti-pharma campaign

27 November 2006

US medical students have been holding their third annual National Pharm Free Day, which consists of a series of events designed to promote the prohibition of pharmaceutical companies from access to university campuses.

American Medical Student Association president Jay Bhatt, in a statement, said: "it is imperative that we, the next generation of physicians, take a stand against drug company influence. It is essential to our professional integrity and to our patients' health that we practise honest, evidence-based medicine."

The PharmFree Campaign was launched in 2002 with the stated objective of educating and training medical students to "professionally and ethically interact with the pharmaceutical industry." The AMSA bans all drug industry advertising at its events and in its publications.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight